Nasdaq Notches More Fresh Highs While Dow, S&P 500 Cool

AUVI chart Feb 9

Biotech name AEterna Zentaris Inc. (Nasdaq: AEZS), meanwhile, is one of the worst performing stocks on the Nasdaq today, down 30.5% at $2.32 at last check. The equity surged to a two-year high of $3.62 yesterday, though the catalyst for these wild moves is not entirely clear. Nevertheless, AEZS sports a 445.2% year-to-date lead. It should be noted, however, that the equity has landed on the short-sell restricted (SSR) list today. 

1 2
View single page >> |

Disclaimer: Schaeffer's Investment Research ("SIR" or "we" or "us") is not registered as an investment adviser. SIR relies upon the "publishers' ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.